指南与共识儿科与产科急症重症综合管理与镇静镇痛

疑似或确诊COVID-19患者的围手术期管理:回顾性队列研究的综述与建议

Perioperative management of patients with suspected or confirmed COVID-19: review and recommendations for perioperative management from a retrospective cohort study.
指南 / 共识 · Br J Anaesth · 2020-09-04
一句话结论疑似或确诊COVID-19患者行非紧急手术前应考虑检测,医护人员围手术期应使用三级个人防护装备,但需进一步研究其时机和规格。

该研究先快速综述2020年1月1日至7月1日文献(26项研究,主要为病例报告/系列),再对武汉同济医院166名剖宫产产妇进行回顾性队列分析。综述发现,择期手术后诊断COVID-19者死亡率高于术前诊断者;30天死亡率较高与急诊手术、大手术、术前状况较差及恶性肿瘤手术相关;多数研究倾向区域麻醉,医护人员普遍使用个人防护装备但对患者使用描述不足。队列中,疑似或确诊患者手术时间、氧疗时间和住院时间均长于阴性患者,但新生儿结局无差异;262名参与医护人员使用三级个人防护装备后无一感染SARS-CoV-2。作者结论认为,疑似COVID-19时非紧急手术前应考虑检测,在进一步证据前医护人员围手术期应使用三级个人防护装备。

要点

  • 疑似或确诊COVID-19患者行非紧急手术前应考虑检测(作者结论)。
  • 医护人员对疑似或确诊患者围手术期应使用三级个人防护装备,262名参与者中无一感染SARS-CoV-2(作者结论)。
  • 择期手术后诊断COVID-19者死亡率高于术前诊断者(一项大型队列报告)。
  • 30天死亡率较高与急诊手术、大手术、术前状况较差及恶性肿瘤手术相关。
  • 疑似或确诊患者剖宫产手术时间、氧疗时间和住院时间均长于阴性患者,但新生儿结局无差异。

适用人群与场景

  • 疑似或确诊COVID-19的围手术期患者,包括行剖宫产的产妇。
  • 参与围手术期管理的医护人员(HCWs)。

处置流程与药物剂量

  • 当怀疑COVID-19时,非紧急手术前应考虑检测(作者结论)。
  • 在进一步证据之前,医护人员对疑似或确诊患者围手术期应使用三级个人防护装备(作者结论)。

研究设计与关键结果

  • 综述纳入26项研究,主要为病例报告/系列。
  • 一项大型队列报告:择期手术后诊断COVID-19的患者死亡率高于术前诊断者。
  • 30天死亡率较高与急诊手术、大手术、术前状况较差及恶性肿瘤手术相关。
  • 多数研究倾向区域麻醉;医护人员普遍使用个人防护装备,但对患者使用描述不足。
  • 回顾性队列纳入武汉同济医院166名剖宫产产妇;疑似或确诊患者手术时间、氧疗时间和住院时间均长于阴性患者,新生儿结局无差异。
  • 262名参与医护人员使用三级个人防护装备围手术期管理,无一感染SARS-CoV-2。

证据类型、等级与局限

  • 证据类型:快速文献综述及单中心回顾性队列研究(166名产妇);综述证据主要基于病例报告/系列。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,疑似COVID-19时非紧急手术前应考虑检测。
  • 作者认为,在进一步证据之前,医护人员对疑似或确诊患者围手术期应使用三级个人防护装备;研究需关注其使用时机和规格。
  • 疑似或确诊患者剖宫产手术时间、氧疗时间和住院时间可能延长,但新生儿结局无差异。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Current guidelines for perioperative management of coronavirus disease 19 (COVID-19) are mainly based on extrapolated evidence or expert opinion. We aimed to systematically investigate how COVID-19 affects perioperative management and clinical outcomes, to develop evidence-based guidelines.

METHODS: First, we conducted a rapid literature review in EMBASE, MEDLINE, PubMed, Scopus, and Web of Science (January 1 to July 1, 2020), using a predefined protocol. Second, we performed a retrospective cohort analysis of 166 women undergoing Caesarean section at Tongji Hospital, Wuhan during the COVID-19 pandemic. Demographic, imaging, laboratory, and clinical data were obtained from electronic medical records.

RESULTS: The review identified 26 studies, mainly case reports/series. One large cohort reported greater mortality in elective surgery patients diagnosed after, rather than before surgery. Higher 30 day mortality was associated with emergency surgery, major surgery, poorer preoperative condition and surgery for malignancy. Regional anaesthesia was favoured in most studies and personal protective equipment (PPE) was generally used by healthcare workers (HCWs), but its use was poorly described for patients. In the retrospective cohort study, duration of surgery, oxygen therapy and hospital stay were longer in suspected or confirmed patients than negative patients, but there were no differences in neonatal outcomes. None of the 262 participating HCWs was infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) when using level 3 PPE perioperatively.

CONCLUSIONS: When COVID-19 is suspected, testing should be considered before non-urgent surgery. Until further evidence is available, HCWs should use level 3 PPE perioperatively for suspected or confirmed patients, but research is needed on its timing and specifications. Further research must examine longer-term outcomes.

CLINICAL TRIAL REGISTRATION: CRD42020182891 (PROSPERO).

来源:Br J Anaesth,查看原文。版权归原作者所有。

参考来源

  1. Zheng H, Hébert HL, Chatziperi A, et al. Perioperative management of patients with suspected or confirmed COVID-19: review and recommendations for perioperative management from a retrospective cohort study. Br J Anaesth. 2020. PMID: 33121750. doi:10.1016/j.bja.2020.08.049

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。